XIAP as a radioresistance factor and prognostic marker for radiotherapy in human rectal adenocarcinoma

American Journal of Pathology

Volumn 181, Issue 4, 2012, Pages 1271-1278

  Moussata, Driffa ^a,b   Amara, Souheila ^b,c   Siddeek, Bénazir ^b,c   Decaussin, Myriam ^a,b   Hehlgans, Stephanie ^d   Paul Bellon, Rachel ^b,c   Mornex, Françoise ^a   Gerard, Jean Pierre ^a   Romestaing, Pascale ^a   Rödel, Franz ^a   Flourie, Bernard ^a   Benahmed, Mohamed ^b,c,e   Mauduit, Claire ^a,b,f  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d GOETHE UNIVERSITY   (Germany)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; IONIZING RADIATION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROPENSITY SCORE; PROTEIN EXPRESSION; RADIOSENSITIVITY; RECTUM CARCINOMA;

ADENOCARCINOMA; APOPTOSIS; CARRIER PROTEINS; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; CELL SURVIVAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; MITOCHONDRIAL PROTEINS; PROGNOSIS; RADIATION TOLERANCE; RADIATION, IONIZING; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84866517256     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.06.029     Document Type: Article

References (44)

1. Colorectal Cancer Collaborative Group Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials Lancet 358 2001 1291 1304
2. C. Rodel, P. Martus, T. Papadoupolos, L. Fuzesi, M. Klimpfinger, R. Fietkau, T. Liersch, W. Hohenberger, R. Raab, R. Sauer, C. Wittekind Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696 (Pubitemid 46211512)
3. N.A. Janjan, J. Abbruzzese, R. Pazdur, V.S. Khoo, K. Cleary, R. Dubrow, J. Ajani, T.A. Rich, M.S. Goswitz, P.A. Evetts, P.K. Allen, P.M. Lynch, J.M. Skibber Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer Radiother Oncol 51 1999 153 160 (Pubitemid 29320309)
4. E. Kapiteijn, C.A. Marijnen, I.D. Nagtegaal, H. Putter, W.H. Steup, T. Wiggers, H.J. Rutten, L. Pahlman, B. Glimelius, J.H. van Krieken, J.W. Leer, C.J. van de Velde Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 2001 638 646
5. J. Giralt, A. Eraso, M. Armengol, J. Rossello, J. Majo, C. Ares, E. Espin, S. Benavente, I. de Torres Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy Int J Radiat Oncol Biol Phys 54 2002 1460 1465 (Pubitemid 35380048)
6. B.D. Minsky, A.M. Cohen, W.E. Enker, L. Saltz, J.G. Guillem, P.B. Paty, D.P. Kelsen, N. Kemeny, D. Ilson, J. Bass, J. Conti Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer Int J Radiat Oncol Biol Phys 37 1997 289 295 (Pubitemid 27138711)
7. M. Mohiuddin, M. Hayne, W.F. Regine, N. Hanna, P.F. Hagihara, P. McGrath, G.M. Marks Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers Int J Radiat Oncol Biol Phys 48 2000 1075 1080
8. R.K. Wong, V. Tandan, S. De Silva, A. Figueredo Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma Cochrane Database Syst Rev 2 2007 CD002102
9. T. Watanabe, Y. Komuro, T. Kiyomatsu, T. Kanazawa, Y. Kazama, J. Tanaka, T. Tanaka, Y. Yamamoto, M. Shirane, T. Muto, H. Nagawa Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles Cancer Res 66 2006 3370 3374
10. T. Suzuki, S. Sadahiro, M. Fukasawa, K. Ishikawa, A. Kamijo, S. Yasuda, H. Makuuchi, Y. Ohizumi, C. Murayama Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer Jpn J Clin Oncol 34 2004 740 746 (Pubitemid 41615271)
11. C. Rodel, G.G. Grabenbauer, T. Papadopoulos, M. Bigalke, K. Gunther, C. Schick, A. Peters, R. Sauer, F. Rodel Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer Int J Radiat Oncol Biol Phys 52 2002 294 303 (Pubitemid 34172996)
12. B.M. Ghadimi, M. Grade, M.J. Difilippantonio, S. Varma, R. Simon, C. Montagna, L. Fuzesi, C. Langer, H. Becker, T. Liersch, T. Ried Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy J Clin Oncol 23 2005 1826 1838 (Pubitemid 46217459)
13. H. Uchida, N. Shinoura, J. Kitayama, T. Watanabe, H. Nagawa, H. Hamada Caspase-8 gene transduction augments radiation-induced apoptosis in DLD-1 cells Biochem Biophys Res Commun 292 2002 347 354 (Pubitemid 34694270)
14. F. Rodel, B. Frey, W. Leitmann, G. Capalbo, C. Weiss, C. Rodel Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models Int J Radiat Oncol Biol Phys 71 2008 247 255 (Pubitemid 351491424)
15. O. Nehls, T. Okech, C.J. Hsieh, M. Sarbia, F. Borchard, H.H. Gruenagel, V. Gaco, R. Porschen, M. Gregor, B. Klump Low BAX protein expression correlates with disease recurrence in preoperatively irradiated rectal carcinoma Int J Radiat Oncol Biol Phys 61 2005 85 91 (Pubitemid 40039109)
16. C. Rebischung, J.P. Gerard, J. Gayet, G. Thomas, R. Hamelin, P. Laurent-Puig Prognostic value of P53 mutations in rectal carcinoma Int J Cancer 100 2002 131 135 (Pubitemid 34666184)
17. D. Sohn, F. Essmann, K. Schulze-Osthoff, R.U. Janicke p21 Blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation Cancer Res 66 2006 11254 11262 (Pubitemid 46009954)
18. A. Degterev, M. Boyce, J. Yuan A decade of caspases Oncogene 22 2003 8543 8567 (Pubitemid 38028527)
19. G. Nunez, M.A. Benedict, Y. Hu, N. Inohara Caspases: the proteases of the apoptotic pathway Oncogene 17 1998 3237 3245 (Pubitemid 29043976)
20. P. Liston, W.G. Fong, R.G. Korneluk The inhibitors of apoptosis: there is more to life than Bcl2 Oncogene 22 2003 8568 8580 (Pubitemid 38019194)
21. D.L. Vaux, J. Silke IAPs: RINGs and ubiquitylation Nat Rev Mol Cell Biol 6 2005 287 297
22. C. Du, M. Fang, Y. Li, L. Li, X. Wang Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 2000 33 42
23. A.L. Dunne, M.E. Price, C. Mothersill, S.R. McKeown, T. Robson, D.G. Hirst Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells Br J Cancer 89 2003 2277 2283 (Pubitemid 38168011)
24. C. Rodel, J. Haas, A. Groth, G.G. Grabenbauer, R. Sauer, F. Rodel Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor Int J Radiat Oncol Biol Phys 55 2003 1341 1347 (Pubitemid 36338302)
25. I. Hammami, S. Amara, M. Benahmed, M.V. El May, C. Mauduit Chronic crude garlic-feeding modified adult male rat testicular markers: mechanisms of action Reprod Biol Endocrinol 7 2009 65
26. A. Bozec, A. Ruffion, M. Decaussin, J. Andre, M. Devonec, M. Benahmed, C. Mauduit Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia J Clin Endocrinol Metab 90 2005 17 25 (Pubitemid 40116628)
27. J.G. Kuremsky, J.E. Tepper, H.L. McLeod Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 2009 673 688
28. S. Huerta, X. Gao, D. Saha Mechanisms of resistance to ionizing radiation in rectal cancer Expert Rev Mol Diagn 9 2009 469 480
29. N. Scott, A. Hale, M. Deakin, P. Hand, F.A. Adab, C. Hall, G.T. Williams, J.B. Elder A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression Eur J Surg Oncol 24 1998 169 173 (Pubitemid 28260606)
30. C.E. Ng, S.K. Banerjee, M. Pavliv, G. Wang, G.P. Raaphorst, R.A. Aubin p53 Status, cellular recovery and cell cycle arrest as prognosticators of in vitro radiosensitivity in human pancreatic adenocarcinoma cell lines Int J Radiat Biol 75 1999 1365 1376
31. W.V. Kastrinakis, N. Ramchurren, K.M. Rieger, D.T. Hess, M. Loda, G. Steele, I.C. Summerhayes Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression Oncogene 11 1995 647 652
32. Y. Kataoka, J.S. Murley, R. Patel, D.J. Grdina Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines Int J Radiat Biol 76 2000 633 639 (Pubitemid 30345164)
33. K.S. Iwamoto, T. Mizuno, T. Ito, N. Tsuyama, S. Kyoizumi, T. Seyama Gain-of-function p53 mutations enhance alteration of the T-cell receptor following X-irradiation, independently of the cell cycle and cell survival Cancer Res 56 1996 3862 3865 (Pubitemid 26284727)
34. P.J. Rochette, N. Bastien, J. Lavoie, S.L. Guerin, R. Drouin SW480, a p53 double-mutant cell line retains proficiency for some p53 functions J Mol Biol 352 2005 44 57 (Pubitemid 41207440)
35. L.D. Zheng, Z.F. Xiong, J.W. Zhu, Z.H. Wang Effects of Smac gene over-expression on the radiotherapeutic sensitivities of cervical cancer cell line HeLa Chin Med J (Engl) 118 2005 226 230
36. H. Takeuchi, J. Kim, A. Fujimoto, N. Umetani, T. Mori, A. Bilchik, R. Turner, A. Tran, C. Kuo, D.S. Hoon X-linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling Clin Cancer Res 11 2005 7621 7628 (Pubitemid 41611602)
37. M. Holcik, R.G. Korneluk XIAP, the guardian angel Nat Rev Mol Cell Biol 2 2001 550 556 (Pubitemid 33673406)
38. H. Sasaki, Y. Sheng, F. Kotsuji, B.K. Tsang Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells Cancer Res 60 2000 5659 5666
39. J. Li, H. Sasaki, Y.L. Sheng, D. Schneiderman, C.W. Xiao, F. Kotsuji, B.K. Tsang Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant Biol Signals Recept 9 2000 122 130 (Pubitemid 30301437)
40. A. Amantana, C.A. London, P.L. Iversen, G.R. Devi X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells Mol Cancer Ther 3 2004 699 707 (Pubitemid 39193751)
41. G.R. Devi XIAP as target for therapeutic apoptosis in prostate cancer Drug News Perspect 17 2004 127 134 (Pubitemid 38568410)
42. R. Berger, C. Jennewein, V. Marschall, S. Karl, S. Cristofanon, L. Wagner, S.H. Vellanki, S. Hehlgans, F. Rodel, K.M. Debatin, A.C. Ludolph, S. Fulda NF-kappaB is required for Smac mimetic-mediated sensitization of glioblastoma cells for gamma-irradiation-induced apoptosis Mol Cancer Ther 10 2011 1867 1875
43. J. Cummings, T.H. Ward, E. LaCasse, C. Lefebvre, M. St-Jean, J. Durkin, M. Ranson, C. Dive Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP Br J Cancer 92 2005 532 538 (Pubitemid 40395534)
44. A.D. Schimmer, S. Dalili, R.A. Batey, S.J. Riedl Targeting XIAP for the treatment of malignancy Cell Death Differ 13 2006 179 188 (Pubitemid 43102202)